The company is a listed pharmaceutical company integrating pharmaceutical research and development, pharmaceutical industry, and pharmaceutical business. The company is mainly engaged in R&D, production and sales of proprietary Chinese medicines, chemical preparations, and chemical raw materials. The company's main products include cough suppressant tablets, gingko biloba dispersible tablets, ginkgo biloba dispersible tablets, Yixin Shu tablets, aluminum magnesium carbonate chewable tablets, Fengliao gastrointestinal health tablets, omeprazole enteric capsules, skin disease blood poison pills, pediatric cough and wheezing tablets, hypoglycemic relief pills, and single active parasitic granules. The company has been successively rated as “Guangdong Pharmaceutical Industry Outstanding Contributing Enterprise”, “Guangdong Province's Top 10 Pharmaceutical Industry Enterprises Comprehensive Strength”, “Guangdong Province's Top 10 Pharmaceutical Industry Enterprises Comprehensive Strength Demonstration Base”, “2018 Top 100 Chinese Medicine Enterprises”, “Innovative Enterprises in Guangdong Province”, “Contract-abiding and Credit-worthy Enterprise”, “Class A Taxpayer”, “AAA Credit Rating Customers”, “Top 100 Tax Paying Enterprises”, “2014 Guangdong Province Top 500 Manufacturing Enterprises”, etc.
Clinical Trials
6
3 active
Approvals
363
Total approvals
Agencies
1
Regulatory bodies
Founded
2002
Active, not recruiting
3
50.0%
Completed
2
33.3%
Terminated
1
16.7%
No news articles found
